Diabetes Drug Class Shows No Clear Bone Risk in New Scan-Based Study
A new observational study from Türkiye found no statistically significant association between SGLT2 inhibitor use and DEXA-derived bone health outcomes ...
Tag: SGLT2 inhibitors
Diabetes Drug Empagliflozin Shows Strong Real-World Results in Pakistan Study
A six-month multicenter study of 952 Pakistani adults found empagliflozin, alone or with metformin, significantly improved HbA1c, weight, and blood ...
SGLT2 Inhibitors Found to Repair Heart Metabolism Through Coenzyme A Pathway
New evidence shows SGLT2 inhibitors protect the failing heart by directly activating PANK1 to restore coenzyme A biosynthesis and myocardial ...
Three Diabetes Drug Classes, One Verdict: Meta-Analysis Confirms Kidney and Heart Protection
A new meta-analysis of 23 randomized trials finds that SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal mineralocorticoid receptor antagonists each ...
Diabetes drug GLP-1 tied to halved stroke risk in study of 171,917 Swedes
A nationwide Swedish cohort study of 171,917 people with type 2 diabetes found GLP-1 receptor agonists were associated with roughly ...
Two Diabetes Drugs, One Powerful Punch: Real-World Data Reveal Semaglutide Plus SGLT2 Inhibitor Benefits
A post hoc analysis of the SCHOLAR study found that over 42 percent of Chinese adults starting semaglutide also took ...
Diabetes Drug Trio Shows Bone-Protecting Power in Rat Study
A new rat study shows that combining canagliflozin, metformin, and fenugreek seed extract improved blood sugar control and preserved femoral ...
Weight-Loss Drugs Outperform Older Diabetes Pills in People with HIV, Real-World Study Finds
A nine-site U.S. cohort study found that GLP-1 receptor agonists produced roughly four times more weight loss than SGLT2 inhibitors ...
Weekly Semaglutide Outperforms Older Diabetes Pills in Protecting Failing Kidneys
A large real-world study finds once-weekly semaglutide outperforms sulfonylureas, DPP4 inhibitors, and thiazolidinediones on blood sugar, weight, blood pressure, and ...
Oral Semaglutide Shows Real-World Heart Protection in Diabetes Patients with Cardiovascular Disease
A large real-world study found that adults with type 2 diabetes and atherosclerotic cardiovascular disease who started oral semaglutide had ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!